Basic Information
| LncRNA/CircRNA Name | MLLT4-AS1 |
| Synonyms | MLLT4 antisense RNA 1 |
| Region | GRCh38_6:167823876-167826709 |
| Ensemble | NA |
| Refseq | NA |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | microarray, qPCR |
| Sample | gastric cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | the downregulation of MLL4-AS1 was significantly associated with advanced Tumor-Node-Metastasis stage (P=0.007) and lymph node metastasis (P=0.008). decreased expression of MLLT4-AS1 is a potential biomarker and a predictor of a poor prognosis for gastric cancer. |
| Pubmed ID | 28927028 |
| Year | 2017 |
| Title | Decreased expression of the long non-coding RNA MLLT4 antisense RNA 1 is a potential biomarker and an indicator of a poor prognosis for gastric cancer |
External Links
| Links for MLLT4-AS1 | GenBank HGNC Noncode |
| Links for gastric cancer | Omim Cosmic |